National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
S01GX09	OLOPAT	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	524,099 L.L
S01GX09	OLOPAT UD	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	1,523,917 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Solution	260,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
S01BA07	OPTILONE	G	Fluorometholone - 0.1%	0.1%	Solution	309,084 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.25mcg	0.25mcg	Capsule	1,138,235 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.25mg	0.25mg	Injectable solution	10,927,526 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
G04CA02	OMNIC OCAS	B	Tamsulosin HCl - 0.4mg	0.4mg	Tablet, film coated, prolonged release	866,778 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.5mg	0.5mg	Injectable solution	10,927,526 L.L
R06AX27	ORADUS	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	199,657 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
M02AA15	OLFEN	G	Diclofenac sodium (diethylamine) - 1%	1%	Gel	268,769 L.L
S01AA13	OPTIFUCIN VISCOUS	G	Fusidic acid - 1%	1%	Drops	208,296 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 1g	1,000mg	Tablet, film coated	657,246 L.L
A11CC05	ONE BIG-D 10.000	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	895,895 L.L
A11CC05	ORAVIL	G	Vitamin D3 - 100,000IU/2ml	100,000IU	Solution	618,168 L.L
L01EX09	OFEV	B	Nintedanib - 100mg	100mg	Capsule, soft	100,972,184 L.L
L01XA03	OXALIPLATIN MEDAC	G	Oxaliplatin - 100mg	100mg	Injectable powder for solution	7,841,801 L.L
L01XA03	OXALIPLATINE VIATRIS 5MG/ML	G	Oxaliplatin - 100mg	100mg	Injectable powder for solution	6,932,000 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	6,199,145 L.L

National Cancer Registry (NCR)